Skip Navigation
Skip to contents

J Trauma Inj : Journal of Trauma and Injury

OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > J Trauma Inj > Volume 39(2); 2026 > Article
Original Article
Resuscitative endovascular balloon occlusion of the aorta (REBOA) as a potential facilitator of definitive fascial closure in the open abdomen: a retrospective study in massive traumatic hemorrhage
Yoonjung Heo, MD1,2orcid, Dong Hun Kim, MD3orcid
Journal of Trauma and Injury 2026;39(2):151-159.
DOI: https://doi.org/10.20408/jti.2025.0310
Published online: June 30, 2026
  • 1,137 Views
  • 18 Download

1Department of Acute Care Surgery, Korea University Guro Hospital, Seoul, Korea

2Department of Trauma Surgery, Armed Forces Trauma Center, Armed Forces Capital Hospital, Seongnam, Korea

3Division of Trauma Surgery, Department of Surgery, Dankook University College of Medicine, Cheonan, Korea

Correspondence to: Dong Hun Kim, MD Division of Trauma Surgery, Department of Surgery, Dankook University College of Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 31116, Korea Tel: +82-41-550-3042 Email: saint7331@gmail.com
• Received: December 8, 2025   • Revised: March 13, 2026   • Accepted: April 15, 2026

© 2026 The Korean Society of Traumatology

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next
  • Purpose
    Resuscitative endovascular balloon occlusion of the aorta (REBOA) effectively reduces uncontrollable torso hemorrhage in trauma. An open abdomen (OA) with temporary abdominal closure commonly follows damage control surgery in such cases. Early definitive fascial closure (DFC) is crucial to prevent complications such as enteric fistula, peritoneal abscess, or chronic ventral hernia. This study aimed to evaluate the effect of REBOA on DFC after massive traumatic hemorrhage.
  • Methods
    This retrospective study analyzed 839 patients requiring massive transfusion at a level I trauma center between 2015 and 2022. Subgroup analyses were conducted among patients who underwent OA and DFC. Primary outcomes were DFC achievement and timing (≤48 hours vs. >48 hours). Secondary outcomes included various clinical outcomes.
  • Results
    Of 229 patients meeting inclusion criteria, 76 (33.2%) required OA management, of whom 33 (43.4%) achieved DFC. The OA+ group demonstrated more severe injury (median Injury Severity Score, 34.0 vs. 22.0; P<0.001) and higher REBOA utilization (47.4% vs. 15.0%, P<0.001). Multivariate analysis showed that bowel perforation (adjusted odds ratio [OR], 6.75; 95% confidence interval [CI], 1.56–29.23; P=0.011) and Sequential Organ Failure Assessment (SOFA) score (adjusted OR, 0.58; 95% CI, 0.43–0.79; P<0.001) were independently associated with DFC achievement; REBOA use was not. Among patients achieving DFC, univariate analysis identified OA indication (OR, 0.11), number of laparotomies (OR, 0.16), and crystalloid volume (OR, 1.00) as factors associated with early closure (≤48 hours), though none remained significant in multivariate analysis.
  • Conclusions
    Zone I REBOA did not significantly influence the achievement or timing of DFC following OA in trauma patients with massive hemorrhage. The deteriorating condition in REBOA recipients and the limited sample size may have affected these findings. Nevertheless, several clinical indicators were associated with DFC, suggesting potential utility in trauma care decisions.
Background
Uncontrolled hemorrhage remains the leading cause of preventable death in trauma, accounting for approximately 30% to 40% of trauma mortality [1]. In patients with non-compressible torso hemorrhage and hemorrhagic shock, resuscitative endovascular balloon occlusion of the aorta (REBOA) has emerged as a valuable adjunct to temporarily control bleeding and maintain central perfusion while definitive surgical intervention is prepared [2]. Zone I REBOA, positioned between the left subclavian artery and the celiac trunk, is particularly effective for intra-abdominal and pelvic hemorrhage [3].
Damage control surgery (DCS) is a well-established approach to severely injured patients, prioritizing physiological restoration over anatomical repair [4]. The fundamental principle involves abbreviated surgical intervention to control hemorrhage and contamination, followed by intensive care unit (ICU) resuscitation to correct the "diamond of death" of hypothermia, acidosis, coagulopathy, and hypocalcemia before definitive repair [5]. An inevitable consequence of DCS is the open abdomen (OA), where temporary abdominal closure (TAC) facilitates subsequent return to the operating room [6].
OA management presents significant challenges, as prolonged OA duration is associated with serious complications, including enteroatmospheric fistula (EAF), intra-abdominal abscess, frozen abdomen, and planned ventral hernia [7,8]. EAF incidence ranges from 5%–55%, carrying mortality rates of 40%–70% [9]. Patients who fail to achieve fascial closure have ventral hernia rates of 32%–51% at 1 year [10]. Consequently, early and successful definitive fascial closure (DFC) is a critical goal in OA management.
Several factors influencing DFC have been identified, including the number of relaparotomies, initial Sequential Organ Failure Assessment (SOFA) score, intra-abdominal complications, and resuscitation volumes [11–13]. The American Association for the Surgery of Trauma (AAST) multicenter study reported a DFC rate of 66% in trauma patients with OA [11]. Negative pressure wound therapy (NPWT) has become the standard TAC technique, with fascial closure rates of 72%–82% depending on the system employed [14].
Objectives
Despite increasing adoption of REBOA in trauma resuscitation, its relationship with OA management and DFC outcomes remains uninvestigated. Theoretically, REBOA may influence DFC through several mechanisms. For example, by reducing hemorrhage and transfusion requirements, REBOA could attenuate the inflammatory response and visceral edema that impede fascial closure. Conversely, ischemia-reperfusion injury from aortic occlusion may exacerbate systemic inflammation and tissue edema [15]. This study, therefore, investigated the impact of zone I REBOA on the achievement and timing of DFC in trauma patients with massive hemorrhage following DCS with OA.
Ethics statement
This study was approved by the Institutional Review Board of Dankook University Hospital (No. DKUH 2024-04-003). Informed consent was waived due to the use of deidentified data and the retrospective nature of the study. The study adhered to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) guidelines.
Study design and patient selection
This retrospective cohort study was conducted at a single level I regional trauma center between January 2015 and August 2022. All trauma patients who received massive transfusion during the study period were identified. Massive transfusion was defined as ≥5 units of packed red blood cells (RBCs) within 4 hours or ≥10 units within 24 hours of admission [16]. Patients were excluded if they met any of the following criteria: (1) severe traumatic brain injury (Abbreviated Injury Scale [AIS] head ≥4); (2) no laparotomy performed; (3) death on arrival or before surgical intervention; (4) transfer to another facility before definitive management; (5) intraoperative death during initial surgery; (6) age ≤15 years; or (7) zone II or III REBOA placement. Zone I REBOA was defined as balloon placement between the left subclavian artery and the celiac trunk, confirmed by portable radiography or fluoroscopy.
REBOA procedure
REBOA was performed by trained trauma surgeons per institutional protocol. Femoral artery access was obtained percutaneously or via surgical cutdown. A 7-Fr sheath was inserted, followed by advancement of the RESCUE balloon catheter (Tokai Medical Products) to zone I, with position confirmed by serial chest radiograph. Balloon inflation and deflation were titrated to hemodynamic response to achieve permissive hypotension.
OA management
Damage control laparotomy was performed according to established principles. The decision to leave the abdomen open was made by the attending trauma surgeon based on physiological derangement, need for reassessment, or inability to achieve tension-free fascial closure [4,6]. TAC was achieved using commercial NPWT systems as the primary method. Patients were returned to the operating room at 24- to 48-hour intervals for washout, reassessment, and attempted DFC, defined as primary approximation of the fascial edges without mesh or component separation techniques.
Data collection and outcomes
Data were extracted from electronic medical records and the institutional trauma database. Variables included demographics (age, sex), injury characteristics (mechanism, Injury Severity Score [ISS], AIS by body region), physiological parameters on arrival (systolic blood pressure, heart rate, Glasgow Coma Scale score, lactate, base deficit, pH), resuscitation data (RBC units, fresh frozen plasma, platelets, cryoprecipitate, crystalloid volume), operative details (number of laparotomies, bowel perforation, vascular injury), and clinical course (SOFA score, abdominal compartment syndrome [ACS], ICU length of stay, hospital length of stay, mortality).
Primary outcomes were DFC achievement (yes/no) and timing (≤48 hours vs. >48 hours). Secondary outcomes included in-hospital mortality, ICU and hospital length of stay, ventilator days, and complications (EAF, intra-abdominal abscess, ACS). ACS was defined per World Society of the Abdominal Compartment Syndrome (WSACS) consensus criteria as sustained intra-abdominal pressure >20 mmHg associated with new organ dysfunction [17].
Statistical analysis
Continuous variables were expressed as medians with interquartile ranges (IQRs) and compared using the Mann-Whitney U-test. Categorical variables were expressed as frequencies and percentages and compared using the chi-square test or Fisher exact test, as appropriate. Univariate logistic regression identified factors associated with DFC achievement and timing. Variables with P<0.1 in univariate analysis were entered into multivariate logistic regression models. Results were reported as odds ratios (ORs) with 95% confidence intervals (CIs). Statistical significance was set at P<0.05. All analyses were performed using R ver. 4.5.1 (R Foundation for Statistical Computing).
Patient characteristics
During the study period, 839 trauma patients requiring massive transfusion were identified. After applying exclusion criteria, 229 patients were included in the final analysis (Fig. 1). Of these, 76 (33.2%) underwent OA management (OA+ group) and 153 (66.8%) achieved primary fascial closure (OA− group). Patient characteristics by OA status are presented in Table 1. The OA+ group demonstrated significantly more severe injury and physiological derangement consistent with advanced hemorrhagic shock. REBOA was utilized more frequently in the OA+ group than in the OA− group (47.4% vs. 15.0%, P<0.001), as were angioembolization (36.8% vs. 8.5%, P<0.001) and preperitoneal pelvic packing (9.2% vs. 0.7%, P=0.002). In-hospital mortality was higher in the OA+ group (71.1% vs. 12.4%, P<0.001).
Subgroup analysis I: Predictors of DFC achievement
Among 76 OA patients, 33 (43.4%) achieved DFC while 43 (56.6%) did not. Factors associated with successful DFC are presented in Table 2. Patients who achieved DFC had significantly lower mean 24-hour RBC transfusion volumes (27.7 units vs. 40.8 units, P=0.001), higher rates of bowel perforation (42.4% vs. 16.3%, P=0.023), higher median total number of laparotomies (2.4 vs. 1.1, P<0.001), and lower mean SOFA scores after OA (9.5 vs. 13, P<0.001). REBOA use did not differ between DFC+ and DFC− groups. In-hospital mortality was significantly lower in patients achieving DFC (33.3% vs. 100%, P<0.001).
On univariate logistic regression, variables associated with DFC achievement included 24-hour RBC transfusion volume (OR, 0.95; 95% CI, 0.92–0.98; P=0.003), bowel perforation (OR, 3.79; 95% CI, 1.31–10.98; P=0.014), and post-OA SOFA score (OR, 0.56; 95% CI, 0.43–0.75; P<0.001) (Table 3). Multivariate logistic regression analysis confirmed that bowel perforation (adjusted OR, 6.75; 95% CI, 1.56–29.23; P=0.011) and post-OA SOFA score (adjusted OR, 0.58; 95% CI, 0.43–0.79; P<0.001) were independently associated with DFC achievement.
Subgroup analysis II: Predictors of early DFC (≤48 hours)
Factors associated with early DFC were analyzed (Table 4). Among 33 patients achieving DFC, 24 (72.7%) achieved closure within 48 hours (mean, 28.7 hours), while 9 (27.3%) required more than 48 hours (mean, 72.0 hours). Early DFC patients had a higher proportion of DCS as the OA indication (91.7% vs. 55.6%), while ACS was more common in the late DFC group (44.4% vs. 8.3%, P=0.034). Early DFC patients also had a lower median total number of laparotomies (2.2 vs. 3.0, P=0.008) and lower mean total crystalloid volume between OA and DFC (4,358.3 mL vs. 10,355.6 mL, P=0.017). REBOA use did not differ between groups.
On univariate logistic regression, early DFC was associated with OA indication (ACS vs. DCS: OR, 0.11 [95% CI, 0.02–0.80], P=0.029), total laparotomies (OR, 0.16; 95% CI, 0.03–0.73, P=0.019), and total crystalloid volume (OR, 1.00; 95% CI, 0.99–1.00, P=0.010) (Table 5). None of these factors remained statistically significant on multivariate analysis.
This study represents the first investigation of the relationship between REBOA and DFC outcomes in trauma patients with massive hemorrhage. Our principal finding is that zone I REBOA does not significantly influence the achievement or timing of DFC following OA. Despite the theoretical potential for REBOA to affect fascial closure by modulating hemorrhage, transfusion requirements, and ischemia-reperfusion injury, our data do not support a clinically meaningful effect in either direction. Several factors may explain the absence of a REBOA effect on DFC. First, REBOA recipients typically represent a more severely injured population with profound hemorrhagic shock, which may mask any potential benefit [2,3]. In our cohort, REBOA recipients exhibited greater physiological derangement and higher ISSs, consistent with the published literature. Second, the potential benefits of REBOA in reducing hemorrhage and transfusion requirements may be counterbalanced by the deleterious effects of aortic occlusion at the tissue level [15]. Zone I occlusion induces splanchnic ischemia, and reperfusion injury upon balloon deflation increases vascular permeability and promotes visceral edema. Matsumoto et al. [18], in a propensity-matched study, demonstrated that REBOA was associated with significantly higher rates of gastrointestinal dysfunction, including feeding intolerance (77% vs. 27%; OR, 9.1; P=0.002), and emphasized that intra-abdominal hypertension should be carefully monitored in REBOA patients. This combination of increased capillary permeability and resuscitation-induced visceral edema creates conditions unfavorable for primary fascial approximation, potentially explaining the observed association between REBOA and OA management in our cohort.
Independent of REBOA, our study identified several clinically relevant predictors of DFC. The inverse association between transfusion volume and DFC achievement on univariate analysis is consistent with previous literature [19]. Aggressive blood resuscitation promotes dilutional coagulopathy and tissue edema, both of which impede fascial closure [20]. Each additional RBC unit transfused was associated with a 5% reduction in the odds of DFC. However, this association did not remain significant on multivariate analysis, suggesting that the effect of transfusion volume may be mediated through organ dysfunction. The independent association between post-OA SOFA score and DFC achievement supports this interpretation. Higher SOFA scores reflect greater systemic physiological derangement, including respiratory, cardiovascular, and renal dysfunction, which compromise wound healing and tissue integrity [21]. The SOFA score is an established predictor of mortality in trauma populations, and our findings extend its utility to predicting fascial closure outcomes [22]. Clinicians should consider incorporating serial SOFA score assessment into decision-making regarding the timing of definitive closure attempts.
The positive association between bowel perforation and DFC achievement warrants careful interpretation. This finding may reflect selection bias, as patients with isolated bowel injuries without significant vascular trauma may exhibit less hemorrhagic shock and better physiological reserve despite requiring OA for contamination control. Alternatively, aggressive source control may create more favorable conditions for subsequent closure. However, hollow viscus injury is strongly associated with subsequent fistula development, with up to 89% of patients developing EAF having antecedent bowel injury repair [23]. Successful DFC in this context should therefore not be interpreted as definitive success; prolonged surveillance for delayed enteric complications remains warranted.
The predictors of early DFC (≤48 hours) provide practical guidance for clinical management. ACS was the strongest negative predictor, with affected patients having 89% lower odds of early closure. This is consistent with its pathophysiology—massive visceral and retroperitoneal edema precluding fascial approximation [24]. The number of laparotomies was also a significant negative predictor, with each additional operation reducing the odds of early closure by 84%. Multiple relaparotomies contribute to fascial retraction, adhesion formation, and cumulative tissue trauma [25,26]; minimizing return trips to the operating room when clinically feasible is therefore advisable. Finally, the association between crystalloid volume and delayed DFC on univariate analysis reflects the known deleterious effects of aggressive fluid resuscitation on tissue edema and wound healing [27,28]. Although this did not reach significance on multivariate analysis, crystalloid administration exceeding 5 L in the first 24 hours has been associated with increased mortality and complications in trauma patients. Our findings support balanced, blood product-based resuscitation with crystalloid restriction, which also underpins ACS prevention [29].
The 100% mortality in the DFC failure group requires clarification. These deaths were attributable to early physiological deterioration rather than prolonged inability to achieve closure, with most patients dying within 48 hours of initial surgery. Among the four patients surviving beyond this period, two died from hemorrhagic shock and two from multiple organ dysfunction syndrome with septic shock. None underwent attempted abdominal closure due to persistent hemodynamic instability and unresolved visceral edema. This pattern indicates that DFC failure in our cohort was driven by injury severity and inadequate physiological reserve rather than technical difficulty with abdominal wall closure, underscoring that successful DFC demands appropriate surgical technique, adequate resuscitation, and resolution of the shock state.
Limitations
This study has several limitations. First, the retrospective single-center design limits generalizability and introduces potential selection bias. REBOA deployment was at individual clinician discretion, and confounding by indication cannot be excluded. Second, the small sample size may have been insufficient to detect modest effects of REBOA on DFC outcomes, and a larger multicenter study would be required to definitively exclude a clinically meaningful effect. Third, detailed data on REBOA occlusion time, inflation/deflation cycles, and partial versus complete occlusion were not captured, all of which may influence outcomes. Fourth, the study period spans evolving practice patterns in both REBOA and OA management, which may have introduced temporal confounding.
Despite these limitations, our study offers a perspective that may inform clinical practice. While most REBOA literature has focused on survival and hemodynamic endpoints, this analysis draws attention to an underexplored but clinically important outcome: abdominal wall reconstruction following damage control laparotomy. By identifying patient- and resuscitation-related predictors of DFC failure, we provide a framework for risk stratification that extends beyond immediate resuscitation success. The finding that bowel injury independently predicts DFC achievement, while paradoxically increasing subsequent fistula risk, illustrates the complexity of recovery in this population and highlights the need for outcome measures that capture the entire surgical course, not merely the initial resuscitation phase.
Future investigation should move beyond descriptive associations toward understanding underlying mechanisms. Prospective studies incorporating biomarkers of ischemia-reperfusion injury and systemic inflammation could help explain why some patients achieve rapid fascial closure while others progress to chronic OA despite similar injury patterns and resuscitation profiles. Partial REBOA, which may reduce distal ischemia while preserving proximal perfusion benefits, deserves particular attention, as its theoretical advantages have yet to be evaluated against abdominal wall outcomes. Ultimately, the goal is not merely to optimize REBOA technique in isolation, but to optimize the entire trajectory of patient recovery.
Conclusions
Zone I REBOA did not significantly influence the achievement or timing of DFC following OA management in trauma patients with massive hemorrhage. The severity of injury in REBOA recipients and the limited sample size may have affected these findings. Nevertheless, this study identified several clinically relevant predictors of DFC, including transfusion volume, SOFA score, bowel perforation, ACS, number of laparotomies, and crystalloid resuscitation volume, which may assist trauma surgeons in optimizing fascial closure decisions and resuscitation strategies. Future prospective multicenter studies are warranted to evaluate the relationship between REBOA and surgical recovery outcomes more comprehensively.

Author contributions

Conceptualization: DHK; Data curation: YH; Formal analysis: YH; Investigation: YH; Methodology: DHK; Project administration: DHK; Visualization: YH; Writing–original draft: YH; Writing–review & editing: all authors. All authors read and approved the final manuscript.

Conflicts of interest

The authors have no conflicts of interest to declare.

Funding

This study was supported by a research fund from Dankook University in 2024.

Acknowledgments

Dr. Han Kyung Ahn made significant contributions during his time as a surgical resident at the hospital, collecting clinical data and presenting an abstract at the Korean Surgical Society. Unfortunately, he is no longer in an academic position and could not be included on the list of authors, but the authors dedicate the honor of this paper's publication to him.

Data availability

Data analyzed in this study are available from the corresponding author upon reasonable request.

Fig. 1.
Study flowchart. RBC; red blood cell; TBI, traumatic brain injury; ED, emergency department; REBOA, resuscitative endovascular balloon occlusion of the aorta; OA, open abdomen; DFC, definitive fascial closure.
jti-2025-0310f1.jpg
Table 1.
Patient characteristics divided by OA status (n=229)
Characteristic OA– group (n=153) OA+ group (n=76) P-value
Age (yr) 53.6±15.7 52.7±16.1 0.679
Male sex 125 (81.7) 62 (81.6) >0.999  
Injury mechanism 0.001
 Traffic accident 104 (68.0) 58 (76.3)
 Stab or cutting wound 21 (13.7) 2 (2.6)
 Fall from height 14 (9.2) 9 (11.8)
 Other 14 (9.2) 7 (9.2)
Blunt trauma 131 (85.6) 74 (97.4) 0.012
Trauma score
 Injury Severity Score 22 (17 to 29) 34 (26 to 41.2) <0.001
 Revised Trauma Score 10 (9 to 11) 8 (5 to 10) <0.001
Cardiac arrest in ED 2 (1.3) 11 (14.5) <0.001
RBC transfusion in 24 hr (unit) 14.3±10.9 35.1±18.0 <0.001
Intervention
 REBOA 23 (15.0) 36 (47.4) <0.001
 Angioembolization 13 (8.5) 28 (36.8) <0.001
 Thoracotomy 7 (4.6) 6 (7.9) 0.366
 Orthopedic damage control 8 (5.2) 1 (1.3) 0.278
 Preperitoneal pelvic packing 1 (0.7) 7 (9.2) 0.002
Initial vital sign
 Systolic blood pressure (mmHg) 99.0 (79.0 to 123.0) 75.0 (56.8 to 101.5) <0.001
 Heart rate (/min) 98.0 (80.0 to 116.0) 100.5 (76.5 to 118.0) 0.818
 Respiratory rate (/min) 21.0 (18.0 to 25.0) 17.0 (8.2 to 24.5) 0.001
 Body temperature (°C) 36.2 (36.0 to 36.5) 36.0 (36.0 to 36.3) 0.010
 GCS score 15 (13 to 15) 9 (3 to 14) <0.001
Initial laboratory test
 pH 7.3 (7.3 to 7.4) 7.2 (7.0 to 7.3) <0.001
 Base excess (mmol/L) –6.3 (–9.1 to –2.7) –12.1 (–18.2 to –7.6) <0.001
 Lactate (mmol/L) 4.1 (2.4 to 5.9) 9.2 (5.6 to 12.9) <0.001
 Hemoglobin (g/dl) 11.3 (9.2 to 13.4) 10.6 (8.4 to 12.7) 0.066
In–hospital mortality 19 (12.4) 54 (71.1) <0.001
Hospital length of stay (day) 28.5±28.3 19.1±34.2 0.042

Values are presented as mean±standard deviation, number (%), or median (interquartile range).

OA, open abdomen; ED, emergency department; RBC, red blood cell; REBOA, resuscitative endovascular balloon occlusion of the aorta; GCS, Glasgow Coma Scale.

Table 2.
Achievement of DFC (subgroup analysis I) (n=76)
Characteristic DFC+ group (n=33) DFC– group (n=43) P-value
Age (yr) 52.7±18.0 52.7±14.8 0.994
Male sex 27 (81.8) 35 (81.4) >0.999
Blunt trauma 32 (97.0) 42 (97.7) >0.999
Injury Severity Score 34 (25–41) 34 (26.5–43) 0.456
REBOA 12 (36.4) 24 (55.8) 0.147
RBC transfusion in 24 hr (unit) 27.7±13.1 40.8±19.4 0.001
OA indication >0.999
 Damage control surgery 27 (81.8) 36 (83.7)
 Abdominal compartment syndrome 6 (18.2) 7 (16.3)
Bowel perforation 14 (42.4) 7 (16.3) 0.023
Total No. of laparotomies 2.4±0.7 1.1±0.3 <0.001
Total volume of crystalloid between OA and DFC (mL) 5,993.9±4,804.6 NA NA
SOFA score after OA 9.5±3.3 13.0±1.7 <0.001
In-hospital mortality  11 (33.3) 43 (100) <0.001
 ≤24 hr 0 28 (65.1)
 >24 to ≤48 hr 0 11 (25.6)
 >48 hr to ≤1 wk 8 (24.2) 4 (9.3)
 >1 wk to ≤60 days 3 (9.1) 0

Values are presented as mean±standard deviation, number (%), or median (interquartile range).

DFC, definitive fascial closure; REBOA, resuscitative endovascular balloon occlusion of the aorta; RBC, red blood cell; OA, open abdomen; NA, not available; SOFA, Sequential Organ Failure Assessment.

Table 3.
Logistic regression predicting successful definitive fascial closure (subgroup analysis I)
Variable Univariate analysis Multivariate analysis
OR (95% CI) P-value aOR (95% CI) P-value
RBC transfusion in 24 hr 0.95 (0.92–0.98) 0.003 0.97 (0.93–1.01) 0.170
Bowel perforation (yes vs. no) 3.79 (1.31–10.98) 0.014 6.75 (1.56–29.23) 0.011
SOFA score after OA 0.56 (0.43–0.75) <0.001 0.58 (0.43–0.79) <0.001

OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; RBC, red blood cell; SOFA, Sequential Organ Failure Assessment; OA, open abdomen.

Table 4.
Time to DFC (subgroup analysis II) (n=33)
Characteristic DFC ≤48 hr group (n=24) DFC >48 hr group (n=9) P-value
Age (yr) 51.5±18.3 55.8±17.9 0.552
Male sex 20 (83.3) 7 (77.8) >0.999
Blunt trauma 23 (95.8) 9 (100) >0.999
Injury Severity Score 34 (28.2–38.8) 27 (25–41) 0.671
REBOA 9 (37.5) 3 (33.3) >0.999
RBC transfusion in 24 hr (unit) 27.5±13.2 28.4±13.5 0.853
OA indication 0.034
 Damage control surgery 22 (91.7) 5 (55.6)
 Abdominal compartment syndrome 2 (8.3) 4 (44.4)
Bowel perforation 11 (45.8) 3 (33.3) 0.698
Total No. of laparotomies 2.2±0.4 3.0±1.0 0.008
Total volume of crystalloid between OA and DFC (mL) 4,358.3±3,107.2 10,355.6±5,928.8 0.017
SOFA score after OA 9.8±2.6 8.9±4.9 0.628
In-hospital mortality 6 (25.0) 5 (55.6) 0.121
Time to DFC (hr) 28.7±12.3 72.0±20.9 NA

Values are presented as mean±standard deviation, number (%), or median (interquartile range).

DFC, definitive fascial closure; REBOA, resuscitative endovascular balloon occlusion of the aorta; RBC, red blood cell; OA, open abdomen; SOFA, Sequential Organ Failure Assessment.

Table 5.
Logistic regression predicting time to definitive fascial closure ≤48 hours (subgroup analysis II)
Variable Univariate analysis Multivariate analysis
OR (95% CI) P-value aOR (95% CI) P-value
OA indication (ACS vs. DCS) 0.11 (0.02–0.80) 0.029 0.14 (0.01–1.47) 0.102
Total No. of laparotomies 0.16 (0.03–0.73) 0.019 0.40 (0.10–1.58) 0.191
Total volume of crystalloid (mL) 1.00 (0.99–1.00) 0.010 1.00 (0.99–1.00) 0.076

OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; OA, open abdomen; ACS, abdominal compartment syndrome; DCS, damage control surgery.

  • 1. Kauvar DS, Lefering R, Wade CE. Impact of hemorrhage on trauma outcome: an overview of epidemiology, clinical presentations, and therapeutic considerations. J Trauma 2006;60(6 Suppl):S3–11.ArticlePubMed
  • 2. DuBose JJ, Scalea TM, Brenner M, et al. The AAST prospective aortic occlusion for resuscitation in trauma and acute care surgery (AORTA) registry: data on contemporary utilization and outcomes of aortic occlusion and resuscitative balloon occlusion of the aorta (REBOA). J Trauma Acute Care Surg 2016;81:409–19.ArticlePubMed
  • 3. Cralley AL, Vigneshwar N, Moore EE, et al. Zone 1 endovascular balloon occlusion of the aorta vs resuscitative thoracotomy for patient resuscitation after severe hemorrhagic shock. JAMA Surg 2023;158:140–50.ArticlePubMedPMC
  • 4. Rotondo MF, Schwab CW, McGonigal MD, et al. 'Damage control': an approach for improved survival in exsanguinating penetrating abdominal injury. J Trauma 1993;35:375–82.ArticlePubMed
  • 5. Wray JP, Bridwell RE, Schauer SG, et al. The diamond of death: hypocalcemia in trauma and resuscitation. Am J Emerg Med 2021;41:104–9.ArticlePubMed
  • 6. Coccolini F, Roberts D, Ansaloni L, et al. The open abdomen in trauma and non-trauma patients: WSES guidelines. World J Emerg Surg 2018;13:7.ArticlePubMedPMC
  • 7. Roberts DJ, Leppäniemi A, Tolonen M, et al. The open abdomen in trauma, acute care, and vascular and endovascular surgery: comprehensive, expert, narrative review. BJS Open 2023;7:zrad084.ArticlePubMedPMC
  • 8. Björck M, Kirkpatrick AW, Cheatham M, Kaplan M, Leppäniemi A, De Waele JJ. Amended classification of the open abdomen. Scand J Surg 2016;105:5–10.ArticlePubMed
  • 9. Di Saverio S, Tarasconi A, Walczak DA, et al. Classification, prevention and management of entero-atmospheric fistula: a state-of-the-art review. Langenbecks Arch Surg 2016;401:1–13.ArticlePubMed
  • 10. Sharrock AE, Barker T, Yuen HM, Rickard R, Tai N. Management and closure of the open abdomen after damage control laparotomy for trauma. A systematic review and meta-analysis. Injury 2016;47:296–306.ArticlePubMed
  • 11. Dubose JJ, Scalea TM, Holcomb JB, et al. Open abdominal management after damage-control laparotomy for trauma: a prospective observational American Association for the Surgery of Trauma multicenter study. J Trauma Acute Care Surg 2013;74:113–20.ArticlePubMed
  • 12. Bradley MJ, Dubose JJ, Scalea TM, et al. Independent predictors of enteric fistula and abdominal sepsis after damage control laparotomy: results from the prospective AAST Open Abdomen Registry. JAMA Surg 2013;148:947–54.ArticlePubMed
  • 13. Hatch QM, Osterhout LM, Ashraf A, et al. Current use of damage-control laparotomy, closure rates, and predictors of early fascial closure at the first take-back. J Trauma 2011;70:1429–36.ArticlePubMed
  • 14. Bruhin A, Ferreira F, Chariker M, Smith J, Runkel N. Systematic review and evidence based recommendations for the use of negative pressure wound therapy in the open abdomen. Int J Surg 2014;12:1105–14.ArticlePubMed
  • 15. Morrison JJ, Ross JD, Markov NP, Scott DJ, Spencer JR, Rasmussen TE. The inflammatory sequelae of aortic balloon occlusion in hemorrhagic shock. J Surg Res 2014;191:423–31.ArticlePubMed
  • 16. Lin VS, Sun E, Yau S, et al. Definitions of massive transfusion in adults with critical bleeding: a systematic review. Crit Care 2023;27:265.ArticlePubMedPMC
  • 17. Kirkpatrick AW, Roberts DJ, De Waele J, et al. Intra-abdominal hypertension and the abdominal compartment syndrome: updated consensus definitions and clinical practice guidelines from the World Society of the Abdominal Compartment Syndrome. Intensive Care Med 2013;39:1190–206.ArticlePubMedPMC
  • 18. Matsumoto S, Aoki M, Funabiki T, Shimizu M. Impact of resuscitative endovascular balloon occlusion of the aorta on gastrointestinal function with a matched cohort study. Trauma Surg Acute Care Open 2024;9:e001239.ArticlePubMedPMC
  • 19. Vogel TR, Diaz JJ, Miller RS, et al. The open abdomen in trauma: do infectious complications affect primary abdominal closure? Surg Infect (Larchmt) 2006;7:433–41.ArticlePubMed
  • 20. Killeen RB, Goldin J. Massive transfusion. In: StatPearls [Internet]. StatPearls Publishing; [updated 2025 Sep 15; cited 2025 Dec 1]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499929/
  • 21. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 1996;22:707–10.ArticlePubMed
  • 22. Antonelli M, Moreno R, Vincent JL, et al. Application of SOFA score to trauma patients. Intensive Care Med 1999;25:389–94.ArticlePubMed
  • 23. Dubose JJ, Lundy JB. Enterocutaneous fistulas in the setting of trauma and critical illness. Clin Colon Rectal Surg 2010;23:182–9.ArticlePubMedPMC
  • 24. Cheatham ML. Abdominal compartment syndrome: pathophysiology and definitions. Scand J Trauma Resusc Emerg Med 2009;17:10.ArticlePubMedPMC
  • 25. Sartelli M, Abu-Zidan FM, Ansaloni L, et al. The role of the open abdomen procedure in managing severe abdominal sepsis: WSES position paper. World J Emerg Surg 2015;10:35.ArticlePubMedPMC
  • 26. Eickhoff R, Guschlbauer M, Maul AC, et al. A new device to prevent fascial retraction in the open abdomen: proof of concept in vivo. BMC Surg 2019;19:82.ArticlePubMedPMC
  • 27. Malbrain ML, Marik PE, Witters I, et al. Fluid overload, de-resuscitation, and outcomes in critically ill or injured patients: a systematic review with suggestions for clinical practice. Anaesthesiol Intensive Ther 2014;46:361–80.ArticlePubMed
  • 28. Cotton BA, Guy JS, Morris JA, Abumrad NN. The cellular, metabolic, and systemic consequences of aggressive fluid resuscitation strategies. Shock 2006;26:115–21.ArticlePubMed
  • 29. Joseph B, Zangbar B, Pandit V, et al. The conjoint effect of reduced crystalloid administration and decreased damage-control laparotomy use in the development of abdominal compartment syndrome. J Trauma Acute Care Surg 2014;76:457–61.ArticlePubMed

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Figure
      • 0
      Resuscitative endovascular balloon occlusion of the aorta (REBOA) as a potential facilitator of definitive fascial closure in the open abdomen: a retrospective study in massive traumatic hemorrhage
      Image
      Fig. 1. Study flowchart. RBC; red blood cell; TBI, traumatic brain injury; ED, emergency department; REBOA, resuscitative endovascular balloon occlusion of the aorta; OA, open abdomen; DFC, definitive fascial closure.
      Resuscitative endovascular balloon occlusion of the aorta (REBOA) as a potential facilitator of definitive fascial closure in the open abdomen: a retrospective study in massive traumatic hemorrhage
      Characteristic OA– group (n=153) OA+ group (n=76) P-value
      Age (yr) 53.6±15.7 52.7±16.1 0.679
      Male sex 125 (81.7) 62 (81.6) >0.999  
      Injury mechanism 0.001
       Traffic accident 104 (68.0) 58 (76.3)
       Stab or cutting wound 21 (13.7) 2 (2.6)
       Fall from height 14 (9.2) 9 (11.8)
       Other 14 (9.2) 7 (9.2)
      Blunt trauma 131 (85.6) 74 (97.4) 0.012
      Trauma score
       Injury Severity Score 22 (17 to 29) 34 (26 to 41.2) <0.001
       Revised Trauma Score 10 (9 to 11) 8 (5 to 10) <0.001
      Cardiac arrest in ED 2 (1.3) 11 (14.5) <0.001
      RBC transfusion in 24 hr (unit) 14.3±10.9 35.1±18.0 <0.001
      Intervention
       REBOA 23 (15.0) 36 (47.4) <0.001
       Angioembolization 13 (8.5) 28 (36.8) <0.001
       Thoracotomy 7 (4.6) 6 (7.9) 0.366
       Orthopedic damage control 8 (5.2) 1 (1.3) 0.278
       Preperitoneal pelvic packing 1 (0.7) 7 (9.2) 0.002
      Initial vital sign
       Systolic blood pressure (mmHg) 99.0 (79.0 to 123.0) 75.0 (56.8 to 101.5) <0.001
       Heart rate (/min) 98.0 (80.0 to 116.0) 100.5 (76.5 to 118.0) 0.818
       Respiratory rate (/min) 21.0 (18.0 to 25.0) 17.0 (8.2 to 24.5) 0.001
       Body temperature (°C) 36.2 (36.0 to 36.5) 36.0 (36.0 to 36.3) 0.010
       GCS score 15 (13 to 15) 9 (3 to 14) <0.001
      Initial laboratory test
       pH 7.3 (7.3 to 7.4) 7.2 (7.0 to 7.3) <0.001
       Base excess (mmol/L) –6.3 (–9.1 to –2.7) –12.1 (–18.2 to –7.6) <0.001
       Lactate (mmol/L) 4.1 (2.4 to 5.9) 9.2 (5.6 to 12.9) <0.001
       Hemoglobin (g/dl) 11.3 (9.2 to 13.4) 10.6 (8.4 to 12.7) 0.066
      In–hospital mortality 19 (12.4) 54 (71.1) <0.001
      Hospital length of stay (day) 28.5±28.3 19.1±34.2 0.042
      Characteristic DFC+ group (n=33) DFC– group (n=43) P-value
      Age (yr) 52.7±18.0 52.7±14.8 0.994
      Male sex 27 (81.8) 35 (81.4) >0.999
      Blunt trauma 32 (97.0) 42 (97.7) >0.999
      Injury Severity Score 34 (25–41) 34 (26.5–43) 0.456
      REBOA 12 (36.4) 24 (55.8) 0.147
      RBC transfusion in 24 hr (unit) 27.7±13.1 40.8±19.4 0.001
      OA indication >0.999
       Damage control surgery 27 (81.8) 36 (83.7)
       Abdominal compartment syndrome 6 (18.2) 7 (16.3)
      Bowel perforation 14 (42.4) 7 (16.3) 0.023
      Total No. of laparotomies 2.4±0.7 1.1±0.3 <0.001
      Total volume of crystalloid between OA and DFC (mL) 5,993.9±4,804.6 NA NA
      SOFA score after OA 9.5±3.3 13.0±1.7 <0.001
      In-hospital mortality  11 (33.3) 43 (100) <0.001
       ≤24 hr 0 28 (65.1)
       >24 to ≤48 hr 0 11 (25.6)
       >48 hr to ≤1 wk 8 (24.2) 4 (9.3)
       >1 wk to ≤60 days 3 (9.1) 0
      Variable Univariate analysis Multivariate analysis
      OR (95% CI) P-value aOR (95% CI) P-value
      RBC transfusion in 24 hr 0.95 (0.92–0.98) 0.003 0.97 (0.93–1.01) 0.170
      Bowel perforation (yes vs. no) 3.79 (1.31–10.98) 0.014 6.75 (1.56–29.23) 0.011
      SOFA score after OA 0.56 (0.43–0.75) <0.001 0.58 (0.43–0.79) <0.001
      Characteristic DFC ≤48 hr group (n=24) DFC >48 hr group (n=9) P-value
      Age (yr) 51.5±18.3 55.8±17.9 0.552
      Male sex 20 (83.3) 7 (77.8) >0.999
      Blunt trauma 23 (95.8) 9 (100) >0.999
      Injury Severity Score 34 (28.2–38.8) 27 (25–41) 0.671
      REBOA 9 (37.5) 3 (33.3) >0.999
      RBC transfusion in 24 hr (unit) 27.5±13.2 28.4±13.5 0.853
      OA indication 0.034
       Damage control surgery 22 (91.7) 5 (55.6)
       Abdominal compartment syndrome 2 (8.3) 4 (44.4)
      Bowel perforation 11 (45.8) 3 (33.3) 0.698
      Total No. of laparotomies 2.2±0.4 3.0±1.0 0.008
      Total volume of crystalloid between OA and DFC (mL) 4,358.3±3,107.2 10,355.6±5,928.8 0.017
      SOFA score after OA 9.8±2.6 8.9±4.9 0.628
      In-hospital mortality 6 (25.0) 5 (55.6) 0.121
      Time to DFC (hr) 28.7±12.3 72.0±20.9 NA
      Variable Univariate analysis Multivariate analysis
      OR (95% CI) P-value aOR (95% CI) P-value
      OA indication (ACS vs. DCS) 0.11 (0.02–0.80) 0.029 0.14 (0.01–1.47) 0.102
      Total No. of laparotomies 0.16 (0.03–0.73) 0.019 0.40 (0.10–1.58) 0.191
      Total volume of crystalloid (mL) 1.00 (0.99–1.00) 0.010 1.00 (0.99–1.00) 0.076
      Table 1. Patient characteristics divided by OA status (n=229)

      Values are presented as mean±standard deviation, number (%), or median (interquartile range).

      OA, open abdomen; ED, emergency department; RBC, red blood cell; REBOA, resuscitative endovascular balloon occlusion of the aorta; GCS, Glasgow Coma Scale.

      Table 2. Achievement of DFC (subgroup analysis I) (n=76)

      Values are presented as mean±standard deviation, number (%), or median (interquartile range).

      DFC, definitive fascial closure; REBOA, resuscitative endovascular balloon occlusion of the aorta; RBC, red blood cell; OA, open abdomen; NA, not available; SOFA, Sequential Organ Failure Assessment.

      Table 3. Logistic regression predicting successful definitive fascial closure (subgroup analysis I)

      OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; RBC, red blood cell; SOFA, Sequential Organ Failure Assessment; OA, open abdomen.

      Table 4. Time to DFC (subgroup analysis II) (n=33)

      Values are presented as mean±standard deviation, number (%), or median (interquartile range).

      DFC, definitive fascial closure; REBOA, resuscitative endovascular balloon occlusion of the aorta; RBC, red blood cell; OA, open abdomen; SOFA, Sequential Organ Failure Assessment.

      Table 5. Logistic regression predicting time to definitive fascial closure ≤48 hours (subgroup analysis II)

      OR, odds ratio; CI, confidence interval; aOR, adjusted odds ratio; OA, open abdomen; ACS, abdominal compartment syndrome; DCS, damage control surgery.


      J Trauma Inj : Journal of Trauma and Injury
      TOP